Paradigm Diagnostics Competitors and Similar CompaniesClear all
Arch Oncology's competitors and similar companies include Divide & Conquer and ARIAD Pharmaceuticals.
 Arch Oncology Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer. |  Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. |  ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. | |
Founding Date | Founding Date 2006 | Founding Date 2018 | Founding Date 1991 |
Type | Type Private | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Brisbane, US HQ St. Louis, US | Locations Babraham, GB HQ | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more |
Employees | Employees 7 | Employees 2 | Employees 1381% increase |
Funding | |||
Latest funding round | Latest funding round $ 105m (about 5 years ago) | Latest funding round $ 12.5m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 155m | Total funding raised $ 12.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Divide & Conquer
HQ
Babraham, GB
Employees
2
Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy.
View companyARIAD Pharmaceuticals
HQ
Cambridge, US
ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.
View company